AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
MUMBAI, Sept 1 Asia Pulse - Wockhardt Ltd (BSE:532300) on Thursday said it has received approval from USFDA for marketing antibiotic Cefotaxime sodium injection in the US market.
The company informed the Bombay Stock Exchange that it received the approval for marketing Cefotaxime sodium in dosages of 1 gm. Cefotaxime sodium is the generic version of Sanofi Aventis Claforan injection and is used in treating a wide variety of infections.
"This is our second approval for sterile cephalosporins, and our sixth approval in the last eight months. ...